Family-Focused Study to Support Medication for Opioid Use Disorder
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Wisconsin, Madison
- Study ID
- NCT07451197
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Opioid Use Disorder
- Opioid Use Disorder, Moderate
- Opioid Use Disorder, Severe
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- FamilyCHESS — BEHAVIORALParticipants will have access to the FamilyCHESS system on their personal smartphone. FamilyCHESS incorporates Invitation to Change (ITC), a combination of Community Reinforcement and Family Training (CRAFT), Acceptance and Commitment Therapy (ACT), and Motivational Interviewing (MI) training principles and components for a CSO (e.g., parent, spouse/romantic partner, adult child, other family member or friend) to encourage and support the patient to engage in treatment.
- Standard of Care — BEHAVIORALParticipants will receive links to Substance Abuse and Mental Health Services Administration (SAMHSA) resources for MOUD
Study Details
The purpose of this clinical trial is to develop and test whether a text- and web-based tool called FamilyCHESS - designed for individuals with opioid use disorder (OUD) and a concerned significant other (CSO) - can help the identified patient (IP) begin and stay on medication for opioid use disorder (MOUD).
Key Dates
- Start date
- Jul 31, 2027
- Status verified
- Mar 2026
- Primary completion
- Jul 31, 2031
- Completion
- Jul 31, 2031
Study Design
- Enrollment
- 338 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: FamilyCHESS (Family Comprehensive Health Enhancement Support System)Participant dyads will receive FamilyCHESS
- Active Comparator: ControlParticipant dyads will receive standard of care treatment for MOUD
Primary Outcome Measure
Initiation of MOUD [ Time Frame: 12 months ]
Central Contacts
- Klaren Pe-Romashko, MS
- Gina Landucci, BS
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60187 | - |
| University of Wisonsin-Madison | Madison | Wisconsin | 53706 | Klaren Pe-Romashko |
Find similar trials in Chicago, IL
Related Studies
- Adjunctive Effects of Psilocybin and a Formulation of BuprenorphinePHASE1 · Recruiting · University of Wisconsin, Madison · Madison, Wisconsin
- A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use DisorderPHASE4 · Recruiting · VA Office of Research and Development · Tuscaloosa, Alabama
- Remotely Observed Methadone Evaluation IIPHASE2 · Recruiting · Sonara Health · Chicago, Illinois
- Integrating MOUD in Nonmedical Community Settings (Better Together)Not Yet Recruiting · Howard University · Washington D.C., District of Columbia